Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation

This publication has 29 references indexed in Scilit:

• Chronic myelogenous leukemia: a concise update
  Blood, 1993
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• Clinical stage of chronic granulocytic leukaemia and BCR breakpoint location in South‐East Asian patients
  British Journal of Haematology, 1989
• Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis
  Cancer Genetics and Cytogenetics, 1988
• The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments]
  Blood, 1988
• Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia
  Blood, 1988
• CML patients in blast crisis have breakpoints localized to a specific region of the BCR
  Blood, 1987
• The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
  Science, 1986
• Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
  Cell, 1984
• Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
  Nature, 1983